These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 24582593)

  • 1. The role of mTOR in depression and antidepressant responses.
    Abelaira HM; Réus GZ; Neotti MV; Quevedo J
    Life Sci; 2014 Apr; 101(1-2):10-4. PubMed ID: 24582593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
    Pałucha-Poniewiera A; Szewczyk B; Pilc A
    Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
    Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
    Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex.
    Abelaira HM; Réus GZ; Ignácio ZM; Dos Santos MA; de Moura AB; Matos D; Demo JP; da Silva JB; Michels M; Abatti M; Sonai B; Dal Pizzol F; Carvalho AF; Quevedo J
    J Psychiatr Res; 2017 Apr; 87():81-87. PubMed ID: 28017918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W; Wang N; Yang C; Li XM; Zhou ZQ; Yang JJ
    Eur Psychiatry; 2014 Sep; 29(7):419-23. PubMed ID: 24321772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mTOR dependent signaling pathway is a necessary mechanism of antidepressant-like activity of zinc.
    Szewczyk B; Pochwat B; Rafało A; Palucha-Poniewiera A; Domin H; Nowak G
    Neuropharmacology; 2015 Dec; 99():517-26. PubMed ID: 26297535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H; Suzuki A; Kunugi A; Tajima Y; Yamada R; Kimura H
    Pharmacol Biochem Behav; 2021 Dec; 211():173289. PubMed ID: 34655652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.
    Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG
    J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
    Lauterbach EC
    Med Hypotheses; 2012 Jun; 78(6):693-702. PubMed ID: 22401777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant action of ketamine via mTOR is mediated by inhibition of nitrergic Rheb degradation.
    Harraz MM; Tyagi R; Cortés P; Snyder SH
    Mol Psychiatry; 2016 Mar; 21(3):313-9. PubMed ID: 26782056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD.
    Zhang B; Guo F; Ma Y; Song Y; Lin R; Shen FY; Jin GZ; Li Y; Liu ZQ
    Sci Rep; 2017 Jun; 7(1):3809. PubMed ID: 28630404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.
    Shen M; Lv D; Liu X; Li S; Chen Y; Zhang Y; Wang Z; Wang C
    Brain Res Bull; 2018 Oct; 143():58-65. PubMed ID: 30316917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition.
    Miller OH; Moran JT; Hall BJ
    Neuropharmacology; 2016 Jan; 100():17-26. PubMed ID: 26211972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA antagonist treatment of depression.
    Williams NR; Schatzberg AF
    Curr Opin Neurobiol; 2016 Feb; 36():112-7. PubMed ID: 26687375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAK-137, an AMPA receptor potentiator with little agonistic effect, produces antidepressant-like effect without causing psychotomimetic effects in rats.
    Suzuki A; Murakami K; Tajima Y; Hara H; Kunugi A; Kimura H
    Pharmacol Biochem Behav; 2019 Aug; 183():80-86. PubMed ID: 31202810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
    Podkowa K; Pochwat B; Brański P; Pilc A; Pałucha-Poniewiera A
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2901-14. PubMed ID: 27286960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways.
    Bettio LE; Cunha MP; Budni J; Pazini FL; Oliveira Á; Colla AR; Rodrigues AL
    Behav Brain Res; 2012 Oct; 234(2):137-48. PubMed ID: 22743004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics.
    Abdallah CG; Sanacora G; Duman RS; Krystal JH
    Annu Rev Med; 2015; 66():509-23. PubMed ID: 25341010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.